← All Trinity Biotech PLC filings

Trinity Biotech PLC F-1 registration statements

The S-1’s counterpart for foreign private issuers registering shares for sale in the United States.

NASDAQ
TRIB
Trinity Biotech PLC
F-1/A: Trinity Biotech PLC: Secondary Offering Update
Trinity Biotech PLC files a post-effective amendment to its F-1 registration statement to update information regarding a secondary offering of up to 33,752,429 ADSs.
NASDAQ
TRIB
Trinity Biotech PLC
F-1: Trinity Biotech Secures $25M Equity Line, Faces Nasdaq Delisting Threat
Trinity Biotech PLC has entered a $25 million equity purchase agreement while simultaneously addressing Nasdaq non-compliance issues and significant debt obligations.
NASDAQ
TRIB
Trinity Biotech PLC
F-1: Trinity Biotech Registers $39M Secondary Offering
Trinity Biotech PLC files to register up to 55.9 million ADSs for resale by Perceptive Credit Holdings, converting existing debt into equity.